Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SiBone (SIBN : NSDQ)

• Company Description    SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. Number of Employees: 376

• Price / Volume Information    Yesterday's Closing Price: $18.62 Daily Weekly Monthly 20 Day Moving Average: 503,579 shares Shares Outstanding: 44.35 (millions) Market Capitalization: $825.78 (millions) Beta: 0.70 52 Week High: $21.89 52 Week Low: $11.48 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.96% -0.25% 12 Week 20.83% 18.28% Year To Date -5.58% -15.77%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 471 EL CAMINO REAL SUITE 101 - SANTA CLARA,CA 95050 USA ph: 408-207-0700 fax: - investors@si-bone.com http://si-bone.com

• General Corporate Information    Officers Laura A. Francis - Chief Executive Officer Jeffrey W. Dunn - Chairman Anshul Maheshwari - Chief Operating Officer & Chief Financial Officer Timothy E. Davis - Director John G. Freund - Director Peer Information SiBone (ABMD) SiBone (DMDS) SiBone (CPWY.) SiBone (EQUR) SiBone (ECIA) SiBone (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 825704109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 44.35 Most Recent Split Date: (:1) Beta: 0.70 Market Capitalization: $825.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.40 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.53 Price/Cash Flow: - Price / Sales: 3.87 EPS Growth vs. Year Ago Period: 35.71% vs. Previous Quarter: 10.00% Sales Growth vs. Year Ago Period: 15.18% vs. Previous Quarter: 6.51% ROE 06/30/26 - -8.23 03/31/26 - -9.56 12/31/25 - -11.01 ROA 06/30/26 - -6.07 03/31/26 - -7.06 12/31/25 - -8.12 Current Ratio 06/30/26 - 9.15 03/31/26 - 9.99 12/31/25 - 8.55 Quick Ratio 06/30/26 - 7.55 03/31/26 - 8.34 12/31/25 - 7.21 Operating Margin 06/30/26 - -6.85 03/31/26 - -8.10 12/31/25 - -9.41 Net Margin 06/30/26 - -6.85 03/31/26 - -8.10 12/31/25 - -9.41 Pre-Tax Margin 06/30/26 - -6.85 03/31/26 - -8.10 12/31/25 - -9.41 Book Value 06/30/26 - 4.11 03/31/26 - 4.04 12/31/25 - 4.09 Inventory Turnover 06/30/26 - 1.22 03/31/26 - 1.21 12/31/25 - 1.22 Debt-to-Equity 06/30/26 - 0.20 03/31/26 - 0.20 12/31/25 - 0.20 Debt-to-Capital 06/30/26 - 16.34 03/31/26 - 16.59 12/31/25 - 16.69

Powered by Zacks Investment Research ©